By Andrea Figueras Fresenius said it reached an agreement to sell the majority of Vamed's rehabilitation business to private equity firm PAI Partners.

(Bloomberg) -- Fresenius SE has agreed to sell a controlling stake in the rehabilitation business of its Vamed unit to French private equity firm PAI Partners as the German healthcare company further ...

Despite contracting rules in place to give veterans safe and affordable access to dialysis, DaVita and Fresenius are picking ...

Fresenius, via its operating company Fresenius Kabi, announced today the immediate U.S. availability of Tyenne ® (tocilizumab-aazg), a biosimilar of Actemra ® (tocilizumab). Tyenne ®, for use ...

The FDA says a recall of Fresenius Medical Care catheter extension sets and luer lock adapters is Class I, the most serious kind.

On April 15, 2024, Fresenius Kabi announced the U.S. launch of its ACTEMRA biosimilar, TYENNE (tocilizumab-aazg) as an intravenous formulation. As we previously reported, Fresenius Kabi received ...

A second recall of Fresenius Kabi’s Ivenix Infusion System this year has been classified Class I by the FDA due to multiple potentially life-threatening anomalies caused by the device’s version 5.8.0 ...

Delhi High Court Income Tax Addition Made Towards Unsubstantiated Share Capital Is Eligible For Section 80-IC Deduction: ...

Closing the gap between basic research and clinical applicationMore than 50 percent of all funded projects received follow-up fundingBad Homburg ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...